BLACK DIAMOND THERAPEUTICS I (BDTX)

US09203E1055 - Common Stock

7.39  +0.43 (+6.18%)

After market: 7.13 -0.26 (-3.52%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
86.46M92.83M126.87M69.57M29.33M
Research and Development
59.35M64.44M96.83M48.21M21.75M
Selling, General, and Administrative Expenses
27.11M28.39M30.04M21.36M7.58M
Operating Income
-86.46M-92.83M-126.87M-69.57M-29.33M
Interest Income/Expense
1.92M-220.00K3.46M4.04M-5.93M
Other Income/Expense
2.09M-350.00K-2.19M-1.73M10.00K
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-82.44M-91.17M-125.60M-67.25M-35.26M
Net Income
-82.44M-91.17M-125.60M-67.25M-35.26M
EBITDA
-86.02M-92.32M-126.66M-69.52M-29.28M
 
Per Share Data
EPS Diluted Total Ops
-1.88-2.51-3.47-2.04-1.08
Non GAAP EPS
-1.88-2.52-3.47-2.05N/A
 
Statistics

All data in USD

Charts